Cargando…
Antiplasmodial profile of selected compounds from Malaria Box: in vitro evaluation, speed of action and drug combination studies
BACKGROUND: Artemisinin-based combination therapy (ACT) is used as the first-line treatment of uncomplicated malaria caused by the Plasmodium falciparum parasite and chloroquine-resistant Plasmodium vivax parasites. Evidence of resistance to ACT has been reported in Cambodia, and without new and eff...
Autores principales: | de Souza, Guilherme Eduardo, Bueno, Renata Vieira, de Souza, Juliana Oliveira, Zanini, Camila Lima, Cruz, Fábio Cardoso, Oliva, Glaucius, Guido, Rafael Victório Carvalho, Aguiar, Anna Caroline Campos |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6938011/ https://www.ncbi.nlm.nih.gov/pubmed/31888654 http://dx.doi.org/10.1186/s12936-019-3069-3 |
Ejemplares similares
-
Synthesis and antiplasmodial assessment of nitazoxanide and analogs as new antimalarial candidates
por: Irabuena, Camila, et al.
Publicado: (2022) -
Phthalimide Derivatives with Bioactivity against Plasmodium
falciparum: Synthesis, Evaluation, and Computational Studies Involving bc(1) Cytochrome Inhibition
por: Okada-Junior, Celso Yassuo, et al.
Publicado: (2018) -
New Derivatives of the Multi-Stage Active Malaria Box Compound MMV030666 and Their Antiplasmodial Potencies
por: Hermann, Theresa, et al.
Publicado: (2022) -
Antiplasmodial activity of iron(II) and ruthenium(II) organometallic
complexes against Plasmodium falciparum blood
parasites
por: de Souza, Nicolli Bellotti, et al.
Publicado: (2015) -
Structural basis of nirmatrelvir and ensitrelvir activity against naturally occurring polymorphisms of the SARS-CoV-2 main protease
por: Noske, Gabriela Dias, et al.
Publicado: (2023)